Operaciones Quanterix - QTRX CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Diferencial | 0.06 | ||||||||
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.024068% | ||||||||
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | 0.001846% | ||||||||
Horario tarifa nocturna | 21:00 (UTC) | ||||||||
Cantidad comercializada mínima | 1 | ||||||||
Divisa | USD | ||||||||
Margen | 20% | ||||||||
Mercado de valores | United States of America | ||||||||
Comisión por operación | 0% |
*Information provided by Capital.com
Cierre previo* | 10.55 |
Abrir* | 10.7 |
Cambio de 1 año* | -60.47% |
Rango del día* | 10.53 - 10.8 |
Rango de 52 semanas | 6.31-31.33 |
Volumen medio (10 días) | 342.04K |
Volumen medio (3 meses) | 6.42M |
Capitalización de mercado | 394.09M |
Ratio P/E | -100.00K |
Acciones en circulación | 37.25M |
Ingresos | 105.52M |
EPS | -2.61 |
Dividendo (Rendimiento %) | N/A |
Beta | 1.34 |
Próxima fecha de resultados | May 8, 2023 |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Cierre | Change | Change (%) | Apertura | High | Low |
---|---|---|---|---|---|---|
Mar 24, 2023 | 10.55 | 0.07 | 0.67% | 10.48 | 10.70 | 10.22 |
Mar 23, 2023 | 10.68 | -0.09 | -0.84% | 10.77 | 11.42 | 10.62 |
Mar 22, 2023 | 10.75 | -1.03 | -8.74% | 11.78 | 11.78 | 10.74 |
Mar 21, 2023 | 11.76 | 0.54 | 4.81% | 11.22 | 11.89 | 11.17 |
Mar 20, 2023 | 11.20 | -0.65 | -5.49% | 11.85 | 11.85 | 11.08 |
Mar 17, 2023 | 11.87 | 0.14 | 1.19% | 11.73 | 12.49 | 11.71 |
Mar 16, 2023 | 12.04 | 0.66 | 5.80% | 11.38 | 12.32 | 11.38 |
Mar 15, 2023 | 11.86 | 0.19 | 1.63% | 11.67 | 12.04 | 11.56 |
Mar 14, 2023 | 12.09 | -0.50 | -3.97% | 12.59 | 12.59 | 11.82 |
Mar 13, 2023 | 12.12 | 0.43 | 3.68% | 11.69 | 12.12 | 11.34 |
Mar 10, 2023 | 11.93 | -0.30 | -2.45% | 12.23 | 12.39 | 11.67 |
Mar 9, 2023 | 12.49 | -0.03 | -0.24% | 12.52 | 13.30 | 12.28 |
Mar 8, 2023 | 12.68 | 0.14 | 1.12% | 12.54 | 12.82 | 12.33 |
Mar 7, 2023 | 12.79 | -0.86 | -6.30% | 13.65 | 14.12 | 12.55 |
Mar 6, 2023 | 13.54 | 2.17 | 19.09% | 11.37 | 13.71 | 11.37 |
Mar 3, 2023 | 12.07 | 1.19 | 10.94% | 10.88 | 12.26 | 10.83 |
Mar 2, 2023 | 10.97 | 0.80 | 7.87% | 10.17 | 10.99 | 10.08 |
Mar 1, 2023 | 10.50 | -0.43 | -3.93% | 10.93 | 11.00 | 10.32 |
Feb 28, 2023 | 10.94 | 0.15 | 1.39% | 10.79 | 11.42 | 10.75 |
Feb 27, 2023 | 10.95 | -0.38 | -3.35% | 11.33 | 11.49 | 10.91 |
Quanterix Events
Hora (UTC) (UTC) | País | Evento |
---|---|---|
No events scheduled |
- Anual
- Trimestral
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Ingresos totales | 105.522 | 110.556 | 86.377 | 56.734 | 37.632 |
Ingresos | 105.522 | 110.556 | 86.377 | 56.734 | 37.632 |
Coste de los ingresos, total | 58.716 | 48.828 | 38.195 | 29.898 | 19.684 |
Beneficio bruto | 46.806 | 61.728 | 48.182 | 26.836 | 17.948 |
Gastos totales de explotación | 207.226 | 169.142 | 117.961 | 98.334 | 69.182 |
Gastos de venta/general/administración Gastos, total | 93.273 | 92.336 | 59.592 | 52.246 | 33.693 |
Investigación y desarrollo | 25.89 | 27.978 | 20.174 | 16.19 | 15.805 |
Ingresos de explotación | -101.704 | -58.586 | -31.584 | -41.6 | -31.55 |
Ingresos por intereses (gastos), netos No operativos | 5.131 | -0.403 | -0.273 | 0.627 | 0.046 |
Otros, netos | -0.062 | 1.265 | -0.049 | -0.01 | -0.007 |
Ingresos netos antes de impuestos | -96.635 | -57.724 | -31.906 | -40.983 | -31.511 |
Ingresos netos después de impuestos | -96.7 | -57.688 | -31.53 | -40.796 | -31.536 |
Beneficio neto antes de partidas extra. Elementos | -96.7 | -57.688 | -31.53 | -40.796 | -31.536 |
Ingresos netos | -96.7 | -57.688 | -31.53 | -40.796 | -31.536 |
Total Adjustments to Net Income | 0 | 0 | |||
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -96.7 | -57.688 | -31.53 | -40.796 | -31.536 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -96.7 | -57.688 | -31.53 | -40.796 | -31.536 |
Ajuste por dilución | |||||
Beneficio neto diluido | -96.7 | -57.688 | -31.53 | -40.796 | -31.536 |
Promedio ponderado de acciones diluidas | 36.991 | 35.9975 | 29.5891 | 25.0907 | 21.9943 |
BPA diluido sin partidas extraordinarias | -2.61415 | -1.60256 | -1.06559 | -1.62594 | -1.43382 |
Dividends per Share - Common Stock Primary Issue | |||||
BPA normalizado diluido | -2.09847 | -1.60256 | -1.06559 | -1.62594 | -1.43382 |
Gastos (ingresos) extraordinarios | 29.347 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Ingresos totales | 25.824 | 26.646 | 23.5 | 29.552 | 30.287 |
Ingresos | 25.824 | 26.646 | 23.5 | 29.552 | 30.287 |
Coste de los ingresos, total | 13.232 | 15.702 | 14.789 | 14.993 | 14.026 |
Beneficio bruto | 12.592 | 10.944 | 8.711 | 14.559 | 16.261 |
Gastos totales de explotación | 47.779 | 63.249 | 48.459 | 47.739 | 50.183 |
Gastos de venta/general/administración Gastos, total | 19.941 | 20.575 | 27.045 | 25.712 | 28.423 |
Investigación y desarrollo | 5.6 | 6.631 | 6.625 | 7.034 | 7.734 |
Ingresos de explotación | -21.955 | -36.603 | -24.959 | -18.187 | -19.896 |
Ingresos por intereses (gastos), netos No operativos | 2.815 | 1.712 | 0.552 | 0.052 | 0.015 |
Otros, netos | 0.614 | -0.101 | -0.358 | -0.217 | -0.213 |
Ingresos netos antes de impuestos | -18.526 | -34.992 | -24.765 | -18.352 | -20.094 |
Ingresos netos después de impuestos | -18.581 | -35.064 | -24.902 | -18.153 | -20.026 |
Beneficio neto antes de partidas extra. Elementos | -18.581 | -35.064 | -24.902 | -18.153 | -20.026 |
Ingresos netos | -18.581 | -35.064 | -24.902 | -18.153 | -20.026 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -18.581 | -35.064 | -24.902 | -18.153 | -20.026 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -18.581 | -35.064 | -24.902 | -18.153 | -20.026 |
Beneficio neto diluido | -18.581 | -35.064 | -24.902 | -18.153 | -20.026 |
Promedio ponderado de acciones diluidas | 37.1842 | 37.0046 | 36.9225 | 36.8509 | 36.6665 |
BPA diluido sin partidas extraordinarias | -0.4997 | -0.94756 | -0.67444 | -0.49261 | -0.54617 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
BPA normalizado diluido | -0.34227 | -0.59026 | -0.67444 | -0.49261 | -0.54617 |
Gastos (ingresos) extraordinarios | 9.006 | 20.341 |
- Anual
- Trimestral
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Total Activo Corriente | 448.955 | 219.605 | 132.661 | 59.496 | 89.252 |
Efectivo e inversiones a corto plazo | 396.465 | 181.584 | 109.155 | 44.429 | 79.682 |
Cash | 6.406 | 1.821 | 1.5 | ||
Inversiones a corto plazo | 102.749 | 42.608 | 78.182 | ||
Total deudores, neto | 23.786 | 17.184 | 10.906 | 6.792 | 5.599 |
Accounts Receivable - Trade, Net | 23.786 | 17.184 | 10.906 | 6.792 | 5.599 |
Total Inventory | 22.19 | 14.856 | 10.463 | 5.945 | 3.571 |
Prepaid Expenses | 6.514 | 5.981 | 2.137 | 2.33 | 0.4 |
Other Current Assets, Total | |||||
Total Assets | 501.527 | 271.045 | 169.951 | 67.611 | 91.779 |
Property/Plant/Equipment, Total - Net | 29.451 | 25.907 | 12.047 | 2.923 | 1.874 |
Property/Plant/Equipment, Total - Gross | 37.156 | 32.343 | 16.386 | 5.946 | 4.297 |
Accumulated Depreciation, Total | -7.705 | -6.436 | -4.339 | -3.023 | -2.423 |
Other Long Term Assets, Total | 2.955 | 1.357 | 1.583 | 1.536 | 0.653 |
Total Current Liabilities | 36.977 | 39.803 | 19.833 | 18.125 | 19.714 |
Accounts Payable | 9.209 | 6.799 | 5.777 | 5.11 | 3.552 |
Accrued Expenses | 21.166 | 16.856 | 9.068 | 7.578 | 6.184 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 7.673 | 0.075 | 0 | 5.036 |
Other Current Liabilities, Total | 6.602 | 8.475 | 4.913 | 5.437 | 4.942 |
Total Liabilities | 60.575 | 64.92 | 41.293 | 26.546 | 25.913 |
Total Long Term Debt | 0 | 0 | 7.587 | 7.623 | 4.346 |
Long Term Debt | 0 | 7.587 | 7.623 | 4.346 | |
Other Liabilities, Total | 21.563 | 22.468 | 13.873 | 0.798 | 1.853 |
Total Equity | 440.952 | 206.125 | 128.658 | 41.065 | 65.866 |
Redeemable Preferred Stock | 0 | ||||
Common Stock | 0.037 | 0.032 | 0.028 | 0.022 | 0.022 |
Additional Paid-In Capital | 745.936 | 451.433 | 345.027 | 216.931 | 210.196 |
Retained Earnings (Accumulated Deficit) | -305.462 | -247.774 | -216.244 | -175.888 | -144.352 |
Total Liabilities & Shareholders’ Equity | 501.527 | 271.045 | 169.951 | 67.611 | 91.779 |
Total Common Shares Outstanding | 36.768 | 31.7965 | 28.1122 | 22.369 | 21.707 |
Goodwill, Net | 9.632 | 10.46 | 9.353 | 1.308 | |
Intangibles, Net | 10.534 | 13.716 | 14.307 | 2.348 | |
Other Equity, Total | 0.441 | 2.434 | -0.153 | ||
Efectivo y Equivalentes | 396.465 | 181.584 | |||
Deferred Income Tax | 2.035 | 2.649 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Total Activo Corriente | 433.706 | 448.955 | 459.429 | 476.44 | 482.443 |
Efectivo e inversiones a corto plazo | 374.317 | 396.465 | 410.747 | 430.78 | 442.672 |
Efectivo y Equivalentes | 374.317 | 396.465 | 410.747 | 430.78 | 442.672 |
Total deudores, neto | 22.616 | 23.786 | 18.434 | 15.43 | 14.936 |
Accounts Receivable - Trade, Net | 22.616 | 23.786 | 18.434 | 15.43 | 14.936 |
Total Inventory | 22.669 | 22.19 | 22.794 | 21.225 | 17.044 |
Prepaid Expenses | 14.104 | 6.514 | 7.454 | 9.005 | 7.791 |
Total Assets | 504.657 | 501.527 | 510.84 | 528.044 | 532.666 |
Property/Plant/Equipment, Total - Net | 48.981 | 29.451 | 28.092 | 27.532 | 26.053 |
Goodwill, Net | 9.323 | 9.632 | 9.903 | 10.121 | 9.933 |
Intangibles, Net | 9.692 | 10.534 | 11.374 | 12.174 | 12.464 |
Other Long Term Assets, Total | 2.955 | 2.955 | 2.042 | 1.777 | 1.773 |
Total Current Liabilities | 31.773 | 36.977 | 31.19 | 37.675 | 36.491 |
Accounts Payable | 4.262 | 9.209 | 5.824 | 6.862 | 6.503 |
Accrued Expenses | 18.049 | 21.166 | 16.425 | 15.324 | 13.889 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 1.993 | 7.716 | 7.694 | |
Other Current Liabilities, Total | 9.462 | 6.602 | 6.948 | 7.773 | 8.405 |
Total Liabilities | 78.249 | 60.575 | 55.326 | 62.034 | 61.197 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Long Term Debt | 0 | ||||
Deferred Income Tax | 1.691 | 2.035 | 2.362 | 2.409 | 2.378 |
Other Liabilities, Total | 44.785 | 21.563 | 21.774 | 21.95 | 22.328 |
Total Equity | 426.408 | 440.952 | 455.514 | 466.01 | 471.469 |
Common Stock | 0.037 | 0.037 | 0.037 | 0.037 | 0.036 |
Additional Paid-In Capital | 750.742 | 745.936 | 739.862 | 734.17 | 728.128 |
Retained Earnings (Accumulated Deficit) | -323.615 | -305.462 | -285.436 | -269.775 | -257.878 |
Other Equity, Total | -0.756 | 0.441 | 1.051 | 1.578 | 1.183 |
Total Liabilities & Shareholders’ Equity | 504.657 | 501.527 | 510.84 | 528.044 | 532.666 |
Total Common Shares Outstanding | 36.8992 | 36.768 | 36.5741 | 36.4544 | 36.2949 |
- Anual
- Trimestral
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Ingresos netos/Línea de salida | -57.688 | -31.53 | -40.796 | -31.536 | -27.019 |
Efectivo de actividades de explotación | -47.907 | -23.365 | -26.187 | -28.721 | -22.106 |
Efectivo de actividades de explotación | 4.851 | 4.312 | 3.009 | 1.352 | 0.482 |
Partidas no monetarias | 17.116 | 11.323 | 7.228 | 5.04 | 2.496 |
Intereses pagados en efectivo | 0.389 | 0.625 | 0.656 | 0.66 | 0.743 |
Cambios en el capital circulante | -12.186 | -7.47 | 4.372 | -3.577 | 1.935 |
Efectivo de actividades de inversión | -6.338 | -0.626 | -25.376 | -5.454 | -1.132 |
Gastos de capital | -13.616 | -3.93 | -10.847 | -1.518 | -1.132 |
Otras partidas de flujo de caja de inversión, total | 7.278 | 3.304 | -14.529 | -3.936 | 0 |
Efectivo procedente de actividades de financiación | 270.795 | 96.236 | 116.197 | -0.078 | 73.249 |
Emisión (retiro) de acciones, neto | 278.533 | 96.311 | 116.247 | 1.851 | 74.229 |
Emisión (amortización) de deuda, neta | -7.738 | -0.075 | -0.05 | -1.929 | -0.98 |
Variación neta de la tesorería | 216.458 | 72.403 | 64.752 | -34.253 | 50.011 |
Efectos del cambio de divisas | -0.092 | 0.158 | 0.118 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -18.153 | -57.688 | -37.662 | -22.001 | -10.104 |
Cash From Operating Activities | -21.695 | -47.907 | -37.615 | -23.838 | -14.089 |
Cash From Operating Activities | 1.358 | 4.851 | 3.566 | 2.344 | 1.151 |
Non-Cash Items | 4.004 | 17.116 | 12.034 | 7.62 | 3.72 |
Cash Interest Paid | 0.389 | 0.389 | 0.309 | 0.154 | |
Changes in Working Capital | -8.904 | -12.186 | -15.553 | -11.801 | -8.856 |
Cash From Investing Activities | -0.874 | -6.338 | -4.144 | -2.129 | 2.435 |
Capital Expenditures | -1.394 | -13.616 | -11.163 | -7.339 | -0.079 |
Other Investing Cash Flow Items, Total | 0.52 | 7.278 | 7.019 | 5.21 | 2.514 |
Cash From Financing Activities | 0.979 | 270.795 | 271.646 | 275.706 | 273.313 |
Issuance (Retirement) of Stock, Net | 0.979 | 278.533 | 277.39 | 275.706 | 273.313 |
Issuance (Retirement) of Debt, Net | -7.738 | -5.744 | 0 | 0 | |
Foreign Exchange Effects | -0.558 | -0.092 | -0.066 | -0.143 | -0.171 |
Net Change in Cash | -22.148 | 216.458 | 229.821 | 249.596 | 261.488 |
Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
---|---|---|---|---|---|---|
Camber Capital Management LP | Hedge Fund | 9.195 | 3425000 | 425000 | 2022-12-31 | MED |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 6.3229 | 2355178 | 69024 | 2022-12-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.9234 | 1833912 | 22903 | 2022-12-31 | LOW |
Millennium Management LLC | Hedge Fund | 4.4167 | 1645165 | -163361 | 2022-12-31 | HIGH |
Frontier Capital Management Company, LLC | Investment Advisor | 4.157 | 1548415 | -386204 | 2022-12-31 | LOW |
Walt (David R) | Individual Investor | 3.8571 | 1436727 | 8083 | 2023-01-03 | LOW |
Granahan Investment Management, Inc. | Investment Advisor | 3.3868 | 1261552 | -11387 | 2022-12-31 | LOW |
Point72 Asset Management, L.P. | Hedge Fund | 2.9285 | 1090826 | 734306 | 2022-12-31 | HIGH |
Platinum Asset Management | Investment Advisor/Hedge Fund | 2.701 | 1006097 | -149721 | 2022-12-31 | LOW |
DWS Investments UK Limited | Investment Advisor | 2.6647 | 992562 | 977677 | 2022-12-31 | MED |
Ashford Capital Management, Inc. | Investment Advisor/Hedge Fund | 2.6087 | 971698 | 69405 | 2022-12-31 | LOW |
Gilder Gagnon Howe & Co. LLC | Hedge Fund | 2.5328 | 943421 | -508171 | 2022-12-31 | LOW |
Hrusovsky (Edward Kevin) | Individual Investor | 2.3495 | 875171 | -960 | 2022-07-05 | LOW |
Portolan Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 2.3148 | 862225 | 103372 | 2022-12-31 | HIGH |
Columbia Threadneedle Investments (UK) | Investment Advisor/Hedge Fund | 2.225 | 828765 | 4753 | 2022-12-31 | LOW |
D. E. Shaw & Co., L.P. | Hedge Fund | 2.0993 | 781974 | 222178 | 2022-12-31 | MED |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 1.8201 | 677948 | 13906 | 2022-12-31 | LOW |
Two Sigma Investments, LP | Hedge Fund | 1.8032 | 671679 | -138437 | 2022-12-31 | HIGH |
Tikvah Management LLC | Hedge Fund | 1.7386 | 647619 | 0 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.7186 | 640159 | 21726 | 2022-12-31 | LOW |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com Group500K+
Traders
92K+
Clientes activos mensualmente
$53M+
Volumen mensual de inversión
$30M+
Retiros por mes
Calculadora de trading
Calcula tus P&L hipotéticas en el supuesto de haber abierto una operación con CFD en una fecha determinada (selecciona una fecha) y haberla cerrado en otra fecha (selecciona una fecha).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Quanterix Company profile
Sobre Quanterix Corp
Quanterix Corporation es una empresa de ciencias de la vida. La empresa se dedica a desarrollar plataformas de inmunoensayos digitales ultrasensibles que hacen avanzar la salud de precisión para la investigación y el diagnóstico en ciencias de la vida. Sus plataformas se basan en su tecnología de detección digital Simoa. Sus plataformas de microesferas y matrices planas Simoa permiten a los clientes detectar de forma fiable biomarcadores de proteínas a concentraciones extremadamente bajas en sangre, suero y otros fluidos. Sus productos incluyen el analizador HD-X, el sistema de detección de biomarcadores SR-X, el sistema de análisis e imágenes SP-X y el arrayer 2470. También suministra anticuerpos NF-Light y kits ELISA, que ofrecen soluciones para la detección de la luz de los neurofilamentos (Nf-L) para el desarrollo de terapias y diagnósticos de enfermedades neurodegenerativas. Su cartera de kits disponibles abarca múltiples áreas terapéuticas, como la cardiología, las enfermedades infecciosas, la inflamación, la neurología y la oncología. Presta servicios a través de su Laboratorio Acelerador Simoa.
Industry: | Advanced Medical Equipment & Technology (NEC) |
900 Middlesex Turnpike
BILLERICA
MASSACHUSETTS 01821
US
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 500.000 traders de todo el mundo que eligen operar con Capital.com